MRNA VACCINES POSE ONGOING CONCERNS IN CHILDREN

A new pediatric study on the effectiveness of the COVID vaccinations on children aged 6 months to 4 years in age has a shocking conclusion. Meanwhile, Moderna is developing an mRNA vaccine for RSV for children that has undergone several safety pauses because of severe injury to babies.